Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine

Neuropsychopharmacology

Volumn 19, Issue 4, 1998, Pages 322-332

  Betancur, Catalina ^a,b,c   Cabrera, Ricardo ^a   De Kloet, E Ronald ^a   Pélaprat, Didier ^b   Rostène, William ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Cocaine; Corticosterone; Locomotion; Neurotensin; Rearing; SR 48692

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; COCAINE; CORTICOSTERONE; GLUCOCORTICOID; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RAT;

ANIMALS; COCAINE; CORTICOSTERONE; DOPAMINE UPTAKE INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOTOR ACTIVITY; NEUROTENSIN; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN; STEREOTYPED BEHAVIOR;

EID: 0031784068     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00028-1     Document Type: Article

References (55)

1. Azzi M, Betancur C, Sillaber I, Spanagel R, Rostène W, Bérod A: Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems. J Neurochem (in press)
2. Baumann MH, Rothman RB (1993): Effects of acute and chronic cocaine on the activity of tuberoinfundibular dopamine neurons in the rat. Brain Res 608:175-179
3. Betancur C, Rostène W, Bérod A (1997): Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum. Mol Brain Res 44:334-340
4. Blaha CD, Coury A, Fibiger HC, Phillips AG (1990): Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: Cross-validation using in vivo voltammetry and microdialysis. Neuroscience 34:699-705
5. 2 dopamine agonists in intact rats. Brain Res 504:276-283
6. Borowsky B, Kuhn CM (1991a): Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther 256:204-210
7. Borowsky B, Kuhn CM (1991b): Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res 543:301-306
8. Brun P, Steinberg R, Le Fur G, Soubrié P (1995): Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. J Neurochem 64:2073-2079
9. Cador M, Kelley AE, Le Moal M, Stinus L (1985): Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology 85:187-196
10. Cain ST, Griff D, Joyner CM, Ellinwood EH, Nemeroff CB (1993): Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions. Neuropsychopharmacology 8:259-265
11. Castel MN, Morino P, Dagerlind A, Hökfelt T (1994): Upregulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur J Neurosci 6:646-656
12. Delfs JM, Schreiber L, Kelley AE (1990): Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303-310
13. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997): Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281:1401-1407
14. Ervin GN, Birkemo LS, Nemeroff CB, Prange AJ Jr (1981): Neurotensin blocks certain amphetamine-induced behaviours. Nature 291:73-76
15. Ferraro L, Tanganelli S, O'Connor WT, Bianchi C, Ungerstedt U, Fuxe K (1995): Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse 20:362-364
16. 11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Brain Res 534:243-250
17. Glimcher PW, Giovino AA, Hoebel BG (1987): Neurotensin self-injection in the ventral tegmental area. Brain Res 403:147-150
18. Glimcher PW, Margolin DH, Giovino AA, Hoebel BG (1984): Neurotensin: A new 'reward peptide.' Brain Res 291: 119-124
19. Gudelsky GA, Berry SA, Meltzer HY (1989): Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology 49:604-609
20. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pélaprat D, Labbé-Jullié C, Mazella J, Soubrié P, Maffrand JP, Rostène W, Kitabgi P, Le Fur G (1993): Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of neurotensin receptor. Proc Natl Acad Sci USA 90:65-69
21. Gygi SP, Gibb JW, Hanson GR (1994): Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions. J Pharmacol Exp Ther 270:192-197
22. Haubrich DR, Gregory EM, Pflueger AB, Williams M (1982): Neurotensin effects on brain dopamine systems. Brain Res 231:216-221
23. Horger BA, Taylor JR, Elsworth JD, Roth RH (1994): Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11:215-222
24. Hökfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M (1984): Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 222:543-559
25. Jolas T, Aghajanian GK (1996): Neurotensin excitation of serotonergic neurons in the dorsal raphe nucleus of the rat in vitro. Eur J Neurosci 8:153-161
26. Kalivas PW, Burgess SK, Nemeroff CB, Prange AJ Jr (1983): Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area. Neuroscience 8:495-505
27. Kalivas PW, Taylor S (1985): Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res 358:70-76
28. Kalivas PW, Duffy P, DuMars LA, Skinner C (1988): Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245:485-492
29. Kalivas PW, Duffy P (1990a): Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci 10:2940-2949
30. Kalivas PW, Duffy P (1990b): The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58
31. Kalivas PW (1993): Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75-113
32. Kalivas PW, Sorge BA, Hooks MS (1993): The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334
33. Kasckow J, Nemeroff CB (1991): The neurobiology of neurotensin: Focus on neurotensin-dopamine interactions. Regul Pept 36:153-164
34. Kelly PH, Seviour PW, Iversen SD (1975): Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522
35. Kelly PH, Iversen SD (1976): Selective 6-OHDA induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56
36. Koob GF (1992): Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
37. Kuhar MJ, Ritz MC, Boja JW (1991): The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
38. MacLennan AJ, Maier SF (1983): Coping and the stress-induced potentiation of stimulant stereotypy in the rat. Science 219:1091-1093
39. Marinelli M, Piazza PV, Deroche V, Maccari S, Le Moal M, Simon H (1994): Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J Neurosci 14:2724-2731
40. Marinelli M, Rougé-Pont F, Deroche V, Barrot M, De Jesus-Oliveira C, Le Moal M, Piazza PV (1997): Glucocorticoids and behavioral effects of psychostimulants. I. Locomotor response to cocaine depends on basal levels of glucocorticoids. J Pharmacol Exp Ther 281:1392-1400
41. Merchant KM, Hanson GR, Dorsa DM (1994): Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: Comparison with acute haloperidol effects. J Pharmacol Exp Ther 269:806-812
42. Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W (1994): Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology 59:572-578
43. Nicot A, Rowe WB, de Kloet ER, Betancur C, Jessop DS, Lightman SL, Quirion R, Rostène W, Bérod A (1997): Endogenous neurotensin regulates hypothalmic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J Neuroendocrinology 9:263-269
44. Piazza PV, Barrot M, Rouge-Pont F, Marinelli M, Maccari S, Abrous DN, Simon H, Le Moal M (1996): Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Natl Acad Sci USA 93:15445-15450
45. Pilotte NS, Mitchell WM, Sharpe LG, De Souza EB, Dax EM (1991): Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain. Synapse 9:111-120
46. Poncelet M, Souilhac J, Gueudet C, Terranova JP, Gully D, Le Fur G, Soubrié P (1994): Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats. Psychopharmacology 116:237-241
47. Rivest R, Jolicoeur FB, Marsden CA (1991): Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo. Neuropharmacology 30:25-33
48. Rivier C, Vale W (1987): Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 422:403-406
49. Robledo P, Maldonado R, Koob GF (1993): Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res 622:105-112
50. Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R (1997): Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity. Neuroendocrinology 66:75-85
51. Santucci V, Gueudet C, Steinberg R, Le Fur G, Soubrié P (1997): Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade. Synapse 26:370-380
52. Steinberg R, Brun P, Fournier M, Souilhac J, Rodier D, Mons G, Terranova JP, Le Fur G, Soubrié P (1994): SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 59:921-929
53. 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: A combined radioautographic and immunohistochemical light microscopic study. J Comp Neurol 279:128-137
54. Tanganelli S, O'Connor WT, Ferraro L, Bianchi C, Beard L, Ungerstedt U, Fuxe K (1994): Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens. Neuroscience 60:649-657
55. Wagstaff JD, Bush LG, Gibb JW, Hanson GR (1994): Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res 665:237-244